CBS Corporation (CBS) Position Trimmed by New York State Common Retirement Fund

Lester Mason
December 7, 2017

(NYSE:CBS) shareholders before Dec 8, 2017 will receive the $0.18 dividend. Next Group Inc has invested 0% in CBS Corporation (NYSE:CBS). This dividend's record date is Dec 11, 2017 and the announcement date is Nov 20, 2017. The stock decreased 0.52% or $0.3 during the last trading session, reaching $57.8. Dupont Capital Management Corp bought a new position in CBS in the 2nd quarter valued at $102,000. (NASDAQ:BLUE) has risen 112.34% since December 6, 2016 and is uptrending. It has outperformed by 1.65% the S&P500. Equities analysts forecast that CBS Co. will post $4.46 earnings per share for the current year.

Several other institutional investors have also sold shares of the company. The SI to Atara Biotherapeutics Incorporated's float is 44.14%. The shares were sold at an average price of $58.40, for a total transaction of $3,161,250.40. Medley Management Inc. (NYSE:MDLY) has declined 2.96% since December 6, 2016 and is downtrending. It has underperformed by 19.66% the S&P500.

CAPITAL WORLD INVESTORS raised its stake in CBS Corporation (NYSE:CBS) by.02% during the September 2017 quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. Its up 0.11, from 0.69 in 2017Q1.

Morgan Stanley started coverage on shares of CBS (NYSE:CBS) in a research note issued to investors on Wednesday. The media conglomerate reported $1.04 EPS for the quarter, topping analysts' consensus estimates of $0.95 by $0.09. Bnp Paribas Asset Management Holding Sa holds 0.02% in CBS Corporation (NYSE:CBS) or 37,570 shares. First Pacific Limited Liability Corp holds 98,850 shares or 0.05% of its portfolio. Tokio Marine Asset Management holds 4,601 shares or 0.04% of its portfolio. Supplemental Annuity Collective Trust Of Nj accumulated 12,000 shares or 0.34% of the stock. Allsquare Wealth Mgmt Ltd Limited Liability Company stated it has 125 shares.

CBS Corporation (NYSE:CBS) now has a "Hold" signals on Composite indicators by TrendSpotter. It also upped General Electric (NYSE:GE) stake by 117,381 shares and now owns 125,475 shares. The Colorado-based Icon Advisers has invested 0.26% in CBS Corporation (NYSE:CBS). Amalgamated Bancorporation reported 0.09% in CBS Corporation (NYSE:CBS). Captrust Financial Advisors owns 241 shares. Zacks Investment Research lowered CBS from a "hold" rating to a "sell" rating in a research report on Tuesday, October 17th.

CBS Corporation operates as a mass media firm worldwide. The firm has a market cap of $24,050.70, a price-to-earnings ratio of 13.98, a P/E/G ratio of 1.08 and a beta of 1.62. The firm operates through four divisions: Entertainment, Cable Networks, Publishing, and Local Media. It has a 84.08 P/E ratio. The Entertainment segment distributes a schedule of news and public affairs broadcasts, and sports and entertainment programming; produces, acquires, and/or distributes programming, including series, specials, news, and public affairs; operates online content networks for information and entertainment; produces, acquires, and distributes theatrical motion pictures; and digital streaming services. Benchmark reiterated a "buy" rating and issued a $81.00 price target on shares of CBS in a report on Wednesday, September 27th. Further, company shares have been seen trading -18.07% off of the 52 week high and 8.87% away from the 52 week low. The company now has a consensus rating of "Buy" and a consensus price target of $71.37. The company was maintained on Monday, May 15 by BMO Capital Markets. The firm has "Buy" rating by Topeka Capital Markets given on Wednesday, November 4. Deutsche Bank has "Buy" rating and $9 target. The rating was maintained by Needham with "Buy" on Friday, November 3. The company was maintained on Friday, October 13 by Barclays Capital. RBC Capital Markets maintained it with "Buy" rating and $7500 target in Tuesday, June 6 report. The stock of CBS Corporation (NYSE:CBS) has "Buy" rating given on Monday, June 12 by Jefferies.

Among 6 analysts covering Atara Biotherapeutics (NASDAQ:ATRA), 4 have Buy rating, 2 Sell and 0 Hold. Therefore 67% are positive. The shares were sold at an average price of $59.04, for a total transaction of $8,856,000.00. Atara Biotherapeutics had 16 analyst reports since September 9, 2015 according to SRatingsIntel. The stock of Atara Biotherapeutics, Inc. (NYSE:MDLY) rating on Tuesday, August 16. On Friday, November 3 the stock rating was maintained by SunTrust with "Buy". The rating was downgraded by Citigroup to "Sell" on Tuesday, December 15. The stock has "Outperform" rating by Barrington Research on Monday, August 10. Jefferies reinitiated Atara Biotherapeutics, Inc. The firm set an "overweight" rating on the media conglomerate's stock. Finally, Needham & Company LLC increased their price target on CBS from $72.00 to $80.00 and gave the company a "buy" rating in a research note on Friday, April 28th. JMP Securities maintained Atara Biotherapeutics, Inc. RBC Capital Markets has "Buy" rating and $77.0 target.

Other reports by Iphone Fresh

Discuss This Article